Caricamento...
Therapeutic value of EGFR inhibition in CRC and NSCLC: 15 years of clinical evidence
Epidermal growth factor receptor (EGFR) plays a key role in tumour evolution, proliferation and immune evasion, and is one of the most important targets for biological therapy, especially for non-small-cell lung cancer (NSCLC) and colorectal cancer (CRC). In the past 15 years, several EGFR antagonis...
Salvato in:
| Pubblicato in: | ESMO Open |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMJ Publishing Group
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5070253/ https://ncbi.nlm.nih.gov/pubmed/27843640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2016-000088 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|